1. Home
  2. JBSS vs ABUS Comparison

JBSS vs ABUS Comparison

Compare JBSS & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John B. Sanfilippo & Son Inc.

JBSS

John B. Sanfilippo & Son Inc.

HOLD

Current Price

$75.01

Market Cap

905.7M

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.56

Market Cap

848.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBSS
ABUS
Founded
1959
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
905.7M
848.8M
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
JBSS
ABUS
Price
$75.01
$4.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$109.00
$5.00
AVG Volume (30 Days)
92.0K
1.2M
Earning Date
04-29-2026
05-14-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
55.26
EPS
4.55
0.87
Revenue
$1,107,246,000.00
$14,083,000.00
Revenue This Year
$5.58
N/A
Revenue Next Year
N/A
$239.71
P/E Ratio
$16.65
$5.28
Revenue Growth
3.79
128.21
52 Week Low
$59.07
$3.04
52 Week High
$85.15
$5.10

Technical Indicators

Market Signals
Indicator
JBSS
ABUS
Relative Strength Index (RSI) 41.40 57.10
Support Level $74.15 $4.16
Resistance Level $77.50 $4.60
Average True Range (ATR) 2.10 0.18
MACD 0.03 0.04
Stochastic Oscillator 19.06 67.81

Price Performance

Historical Comparison
JBSS
ABUS

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: